Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2011
09/21/2011EP1945630B1 Pyrazine derivatives as sodium channel modulators for the treatment of pain
09/21/2011EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase
09/21/2011EP1505963B9 Hepatitis c virus inhibitors
09/21/2011EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate
09/21/2011CN102197035A Novel crystalline form and processes for its preparation
09/21/2011CN102197034A Novel polymorphs of sunitinib and processes for their preparation
09/21/2011CN102197031A Substituted 5-aminopyrazoles and use thereof
09/21/2011CN102196809A Agent for treatment of diabetic nephropathy
09/21/2011CN102190653A Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
09/21/2011CN102190652A Preparation method of losartan metabolite EXP-3174
09/21/2011CN102190628A Preparation method of 5-fluoro-6-ethyl-4-hydroxypyrimidine intermediate and Voriconazole
09/21/2011CN102190627A 9,10-phenanthroimidazole derivatives and use thereof as electroluminescent materials
09/21/2011CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs
09/21/2011CN102190621A N-heterocyclyl-phenylsubstituierte cyclische ketoenole
09/21/2011CN101538236B Method for synthesizing lauroyl-prolyl amino acid methyl ester as novel transdermal enhancer and applications thereof
09/21/2011CN101343250B Thrombopoietin mimetics
09/20/2011US8022221 Aurora kinase modulators and method of use
09/20/2011US8022210 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma
09/20/2011US8022209 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
09/20/2011US8022206 Furo[3,2-C]pyridines
09/20/2011US8022111 Piperazino sensitisers
09/20/2011US8022097 Adamantane-dipyrromethane derivatives, method of preparation and applications in anion sensing
09/20/2011US8022096 Pyrrolidine derivatives
09/20/2011US8022085 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof
09/20/2011US8022073 Substituted pyridazine compounds and fungicidal uses thereof
09/20/2011US8022071 Nitrogenous heterocyclic compounds
09/20/2011US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
09/20/2011US8022061 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions
09/20/2011CA2645856C Pyrazoles as 11-beta-hsd-1
09/20/2011CA2583737C Compounds and compositions as protein kinase inhibitors
09/20/2011CA2541458C Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
09/20/2011CA2505033C Non-nucleoside reverse transcriptase inhibitors
09/20/2011CA2503868C Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
09/20/2011CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/20/2011CA2462903C Beta-lactamyl vasopressin v1a antagonists
09/20/2011CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
09/20/2011CA2443403C 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
09/20/2011CA2439415C Cathepsin cysteine protease inhibitors
09/15/2011WO2011112766A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011WO2011112428A2 Arylvinylazacycloalkane compounds for constipation
09/15/2011WO2011112191A1 Compounds for the treatment of hepatitis c
09/15/2011WO2011111930A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/15/2011WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/15/2011WO2011111077A1 1, 2, 4-triazole derivatives and their anti mycobacterial activity
09/15/2011WO2011110852A1 Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
09/15/2011WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
09/15/2011WO2011110198A1 A process for making voriconazole
09/15/2011US20110224434 Prodrugs of Heteroaryl Compounds
09/15/2011US20110224432 Heteroaryl compounds and uses thereof
09/15/2011US20110224334 Near-infrared-ray absorbing material containing cyanine compound, and cyanine compound
09/15/2011US20110224273 Pyrazole Derivatives as 11-Beta-HSD1 Inhibitors
09/15/2011US20110224271 process for the preparation of olmesartan medoxomil
09/15/2011US20110224259 Novel inhibitors
09/15/2011US20110224255 Tripeptidyl peptidase inhibitors
09/15/2011US20110224254 Novel inhibitors
09/15/2011US20110224230 Bicyclic dihydroimidazolone cgrp receptor antagonists
09/15/2011US20110224229 Novel Crystalline Form
09/15/2011US20110224219 Melanocortin receptor agonists
09/15/2011US20110224211 Anti-Viral Compounds, Compositions, And Methods Of Use
09/15/2011US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases
09/15/2011US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
09/15/2011US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents
09/15/2011US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal
09/15/2011CA2792539A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/15/2011CA2792157A1 Arylvinylazacycloalkane compounds for constipation
09/15/2011CA2791417A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/15/2011CA2789440A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
09/14/2011EP2364974A1 N-(3-Phenylamino-quinoxalin-2-yl)-benzenesulfonamide derivatives as phosphatidylinositol 3-kinase inhibitors
09/14/2011EP2364964A1 Novel anthracene derivative and organic electronic device using the same
09/14/2011EP2364312A2 Preparation of crystalline palonosetron hydrochloride
09/14/2011EP2364310A2 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
09/14/2011EP2364309A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
09/14/2011EP2364308A1 Pyrazine compounds as phosphodiesterase 10 inhibitors
09/14/2011EP2364307A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine
09/14/2011EP2364302A2 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
09/14/2011EP2364296A1 Pyrrolidines
09/14/2011EP2364295A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists
09/14/2011EP2364185A1 Disubstituted phthalazine hedgehog pathway antagonists
09/14/2011EP2231636B1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
09/14/2011EP2049501B1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
09/14/2011EP1911755B1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
09/14/2011EP1871374B1 2,3 substituted pyrazine sulfonamides as inhibitors of crth2
09/14/2011EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/14/2011EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/14/2011EP1471915B1 2,4-pyrimidinediamine compounds and their uses
09/14/2011EP1446401B1 C5-modified indazolylpyrrolotriazines
09/14/2011EP1346982B1 Vla-4 inhibitors
09/14/2011CN1642551B Inhibitors of histone deacetylase
09/14/2011CN102186841A 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
09/14/2011CN102186840A Piperidine compounds, pharmaceutical composition comprising the same and its use
09/14/2011CN102186839A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
09/14/2011CN102186838A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
09/14/2011CN102186818A 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
09/14/2011CN102186816A Pesticidal (hetero) arylpyrrolidines
09/14/2011CN102186809A Insecticidal 4-phenyl-1h-pyrazoles
09/14/2011CN102186477A Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
09/14/2011CN102186475A Novel inhibitors
09/14/2011CN102181171A Iso-indigo derivative and applications of the iso-indigo derivative
09/14/2011CN102180867A Synthesis method of N-{2-[4-(2-pyrimidyl)-1-piperazine}adamantine-1-formide
09/14/2011CN101786997B Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide